USE THE SUGAMMADEX IN THE CHILDRENS (LITERATURE REVIEW)

Cover Page


Cite item

Full Text

Abstract

The article presents a review of the literature on the use of a selective inhibitor of aminosteroid muscle relaxants (rocuronium and vecuronium) sugammadex in children. Considered versatile aspects of sugammadex to eliminate neuromuscular block with the age of children, their features physiology, comorbidity, complications encountered. Provides links to descriptions of unusual rare cases of clinical practice of sugammadex in childhood.

About the authors

V. V. Lazarev

Russian National Research Medical University named after N.I. Pirogov

Author for correspondence.
Email: noemail@neicon.ru
Россия

T. Y. Minorskaya

Russian National Research Medical University named after N.I. Pirogov

Email: noemail@neicon.ru
Россия

References

  1. Агавелян Э.Г., Степаненко С.М., Гулидова А.Н. Устранение нейромышечного блока у детей: современный подход // Вестник анестезиологии и реаниматологии. 2012. Т. 9. № 6. C. 12-16.
  2. Матинян Н.В., Салтанов А.И., Мареева А.А. Опыт применения сугаммадекса для реверсии нейромышечного блока при операциях в детской онкологии // Анестезиология и реаниматология. 2013. № 1. С. 34-37
  3. Asahi Y., Omichi S., Adachi S. et al. Hypersensitivity reaction probably induced by sugammadex // Acta Anaesthesiol Taiwan. 2012, Dec. Vol. 50, N 4. Р. 183-184.
  4. Baxter M.R., Bevan J.C., Samuel J. еt al. Postoperative neuromuscular function in pediatric day-care patients. Anesth Analg 1991; 72:504-8.
  5. Benoit Plaud, Olli Meretoja, Rainer Hofmockel et al. Reversal of Rocuronium-induced Neuromuscular Blockade with Sugammadex in Pediatric and Adult Surgical Patients // Anesthesiology. 2009. Vol. 110. Р. 284-294.
  6. Brandom B.W., Fine G.F. Neuromuscular blocking drugs in pediatric anesthesia // Anesthesiol. Clin. North America. 2002. Vol. 20. Р 45-58.
  7. Cammu G., Coart D., De Graeve K. et al. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: a prospective observational study // Acta Anaesthesiol. Belg. 2012. Vol. 63, № 2. Р. 69-73.
  8. Chon J.Y. In the hour of Sugammadex // Kor.J. Anesthesiol. 2013, Jan. Vol. 64, № 1. Р. 3-5.
  9. Della Rocca G., Pompei L. A novel approach to reversal of neuromuscular blockade // Minerva Anestesiol. 2009. Vol. 75. Р. 349-351.
  10. Doi Y., Kagawa T. Update on the practical use of new anesthetic agents // Masui. 2013, Sep. Vol. 62, № 9. Р. 1088-1096.
  11. Fisher D.M. Neuromuscular blocking agents in paediatric anaesthesia // Br.J. Anaesth. 1999. Vol. 83. Р. 58-64.
  12. Francisci G., Papasidero A.E., Spinazzola G. Update on complications in pediatric anesthesia // Pediatric Reports. 2013. N 5. e2:8-12.
  13. Gaona D., Carcelec M.D., Veiga G., Tedesco M., Motta P. Efficacy and safety of the reversal with sugammadex in deep neuromuscular blockade induced by rocuronium in pediatrics // Br. J. Anaesthesia. 2012. Vol. 108, № 52. Р. 308-309.
  14. Godai K., Hassegawa-Moriyama M., Kuniyoshi T. et al. Three cases of suspected sugammadex-induced hypersensitivity reactions // Br.J. Anaesth. 2012, Aug. Vol. 109, № 2. Р. 216-218.
  15. Grosse-Sundrup M., Henneman J.P., Sandberg W.S. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study // BMJ. 2012. Vol. 15. Р. 345.
  16. Hayes J., Veyckemans F., Bissonnette B. Duchenne muscular dystrophy: an old anesthesia problem revisted // Pediatr. Anesth. 2008. Vol. 18. Р. 100-106.
  17. Hepner D.L., Castells M.C. Anafilaxis during the perioperative period // Anesthesia and Analgesia. 2013. Vol. 97. Р. 1381-1395.
  18. Holzki J. Recent advances in pediatric anesthesia // Korean J. Anesthesiol. 2011, May. Vol. 60, № 5. Р. 313-322.
  19. Illman H.L., Laurila P., Antila H. et al. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring // Anesth. Analg. 2011, Jan. Vol. 112, № 1. Р. 63-68.
  20. Jones P.M., Turkstra T.P. Mitigation of rocuronium induced anaphylaxis by sugammadex: the great unknown // Anaesthesia. 2010. Vol. 65. Р. 89-90.
  21. Jones R.K., Caldwell J.E., Brull S.J. et al. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine // Anesthesiology. 2008, Nov. Vol. 109, № 5. Р. 816-824.
  22. Kim K.S., Lew S.H., Cho H.Y., Cheong M.A. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine // Anesth. Analg. 2002, Dec. Vol. 95, № 6. Р. 1656-1660.
  23. Kopman A.F., Kopman D.J., Ng J. et al. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function // J. Clin. Anesth. 2005, Feb. Vol. 17, № 1. Р. 30-35.
  24. Lazarev V., Tsypin L., Rassaus P., Kochkin V., Negoda P. Application sugammadex in children // Br. J. Anaesthesia. 2012. Vol. 108, № 52. Р. 288-289.
  25. Laxenaire M.C., Mertes P.M., Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques. Anaphylaxis during anaesthesia. Results of a two-year survey in France // Br. J. Anaesthesia. 2001. Vol. 87. Р. 549-558.
  26. Makri I., Papadima A., Lafioniati A. et al. Sugammadex, a promising reversal drug. A review of clinical trials // Rev. Recent. Clin. Trials. 2011. Vol. 6, № 3. Р. 250-255.
  27. Marsch S.C., Steiner L., Bucher E. Succinylcholine versus rocuronium for rapid sequence intubation in intensive care: a prospective, randomized controlled trial // Crit. Care. 2011. Vol. 15. R199.
  28. Medina Ramirez S., Milena Sanchez A., Gomez Oquendo F. Sugammadex en un paciente con insuficiencia renal cronica // Revista Colombiana de Anestesiologia. 2011. Vol. 39, № 3. Р. 433-443.
  29. Mendez-Ozcotidi L., Ortiz-Gomez J.R., Olaguibel-Ribero J.M. et al. Allergy to low dose sugammadex // Anaesthesia. 2011, Mar. Vol. 66, № 3. Р. 217-219.
  30. Mertes P.M., Laxenaire M.C., Groupe d'Etudes des Re actions Anaphylac- to IdesPeranesthe siques. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001- December 2002) // Ann. Franc. d’Anesthesie et de Reanimation. 2004. Vol. 23. Р. 1133-1143.
  31. Motoyama Y., Izuta S., Maekawa N. et al. Case of anaphylactic reaction caused by sugammadex // Masui. 2012, Jul. Vol. 61, № 7. Р. 746-748.
  32. Murphy G.S., Brull S.J. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block // Anesth. Analg. 2010. Vol. 111, № 1. Р. 120-128.
  33. Murphe G.S. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period // Minerva Anestesiol. 2006. Vol. 72, № 3. Р. 97-109.
  34. Nishi M., Fujii S., Nitta S. A two-year-old patient who received readministration of rocuronium for re-operation 30 minutes after sugammadex reversal // Masui. 2011, Oct. Vol. 60, № 10. Р. 1189-1191.
  35. Noulas N., Loukas G., Malimanis D. et al. Calculating dose of sugammadex in obese male children undergoing minor urological procedures // Br.J. Anaesthesia. 2012. Vol. 108, № 52. Р. 308-309.
  36. Ohshita N., Tsutsumi Y.M., Kasai A. et al. Two cases of anaphylactoid reaction after administration of sugammadex // Masui. 2012, Nov. Vol. 61, № 11. Р. 1261-1264.
  37. Pavoni V., Gianwswllo L., De Scisciolo G. et al. Reversal of profound and «deep» residual rocuronium-induced neuromuscular blockade by sugammadex: a neurophysiological study // Minerva Anestesiol. 2012. Vol. 78, № 5. Р. 542-549.
  38. Plaud B., Meretoja O., Hofmockel R. et al. Reversal of Rocuronium-induced neuromuscular Blockade with Sugammadex in Pediatric and Adult Surgical Patients // Anesthesiology. 2009. Vol. 110. Р. 284-291.
  39. Rawicz M., Brandom B., Wolf A. The place of suxamethonium in pediatric anesthesia // Pediatr. Anesth. 2009. Vol. 19. Р. 561-570.
  40. Sacan O., White P.F., Tufanogullari B. et al. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine // Anesth. Analg. 2007, Mar. Vol. 104, № 3. Р. 569-574.
  41. Takeda A., Kawamura M., Hamaya I. Case of anesthesia for thoracoscopic thymectomy in pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex // Masui. 2012. Vol. 61, № 8. Р. 855-858.
  42. Yang L.P., Keam S.J. Sugammadex: a review of its use in anaesthetic practice // Drugs. 2009. Vol. 69. Р. 919-942.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Lazarev V.V., Minorskaya T.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 81892 от 24.09.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies